Home › Lung Cancer › NCT00899405
Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer
RecruitingObservational study
EGFR Pathway Mutations in Lung Cancer Patient Tumors and Blood
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
DISEASE CHARACTERISTICS: * Histologically or cytologically confirmed lung cancer PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * May have received prior EGFR inhibitors
About the study
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This laboratory study is looking at tumor tissue samples and blood samples to learn more about DNA changes in patients with lung cancer.
Sponsor: University of California, Davis · Participants: 800 · Started: May 19, 2004
Contact the study team
- Office of Clinical Research · Phone: 916-382-6970
Official record on ClinicalTrials.gov — NCT00899405
Locations in the U.S.
| California | University of California Davis Cancer Center, Sacramento |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.